Page 100 - 《中国药房》2024年1期
P. 100

·药师与药学服务·


          实体器官移植受者接受霉酚酸类药物TDM的意愿调查                                                             Δ


          刘 爽    1, 2* ,陈鸿圣  1, 2, 3 ,郭 琦  1, 2, 3 ,程吟楚 ,赵荣生 ,侯小飞 (1. 北 京 大 学 第 三 医 院 药 剂 科 ,北 京
                                                             1, 2
                                                                       4 #
                                                   1, 2
          100191;2.北京大学医学部药品评价中心,北京 100191;3.北京大学药学院药事管理与临床药学系,北京
          100191;4.北京大学第三医院泌尿外科,北京 100191)


          中图分类号  R969.3;S857.13+4      文献标志码  A      文章编号  1001-0408(2024)01-0090-05
          DOI  10.6039/j.issn.1001-0408.2024.01.16

          摘   要  目的  调查实体器官移植受者接受霉酚酸类(MPA)药物治疗药物监测(TDM)的意愿,并探究相关影响因素,为相关指南
          推荐意见形成及临床决策优化提供参考。方法  采用横断面研究设计法,设计MPA TDM患者意愿调查问卷,选取2022年4月14
          日至2022年6月27日在北京市两家三级甲等综合医院接受MPA类药物治疗的实体器官移植受者进行调研。采用Likert 5级评分
          法对患者接受MPA TDM的意愿进行评分,采用Pearson相关分析和二元Logistic回归分析患者接受MPA TDM的意愿影响因素及
          其相关性,采用非参数检验和χ 检验对影响患者意愿决策的因素进行排序及一致性分析。结果  共收集到有效问卷140份,有效
                                  2
          回收率为77.35%。140例患者接受MPA TDM的平均意愿得分为(4.01±0.65)分,表明总体意愿值较高;有116例(82.86%)患者表
          示愿意或非常愿意接受 MPA TDM;既往接受过 TDM 与未接受过 TDM 患者的意愿得分差异有统计学意义[(4.30±0.53)分 vs.
         (3.80±0.65)分,P<0.001]。患者对MPA TDM的了解程度、重视程度与接受意愿呈显著正相关(P<0.001)。患者决策影响因素
          排序具有统计学上的一致性(P<0.001),影响程度由大到小分别为治疗有效性、安全性、舒适程度、经济性及时间成本。结论  实
          体器官移植受者对MPA TDM的接受意愿较高,MPA TDM既往就诊经历和对MPA TDM的了解、重视程度为影响患者意愿的主要
          因素。
          关键词  霉酚酸类药物;治疗药物监测;患者意愿;实体器官移植;问卷调查


          Investigation  of  patients’  preferences regarding therapeutic drug  monitoring of  mycophenolic acid in  solid
          organ transplantation
          LIU Shuang ,CHEN Hongsheng     1, 2, 3 ,GUO Qi 1, 2, 3 ,CHENG Yinchu ,ZHAO Rongsheng ,HOU Xiaofei  4
                     1, 2
                                                                                             1, 2
                                                                         1, 2
         (1.  Dept.  of  Pharmacy,  Peking  University  Third  Hospital,  Beijing  100191,  China;2.  Institute  for  Drug
          Evaluation,  Peking  University  Health  Science  Center,  Beijing  100191,  China;3.  Dept.  of  Pharmacy
          Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191,
          China;4. Dept. of Urology, Peking University Third Hospital, Beijing 100191, China)


          ABSTRACT    OBJECTIVE  To  investigate  the  preferences  of  patients  who  underwent  solid  organ  transplantation  regarding
          therapeutic  drug  monitoring (TDM)  of  mycophenolic  acid (MPA)  and  explore  the  factors  influencing  patients’  decision-making
          process, so as to provide support for the development of individualized medication guidelines for MPA and improvement of clinical
          decision-making. METHODS The cross-sectional study was used to design the questionnaire on the patients’ preferences to accept
          MPA TDM,  and  involved  patients  who  underwent  solid  organ  transplantation  and  received  MPA  treatment  at  two  tertiary  hospitals
          in Beijing from April 14, 2022, to June 27, 2022. The Likert 5-level scoring method was used to score the patients’ preferences to
          accept MPA TDM, the influencing factors and their correlation of the patients’ preferences to accept MPA TDM were analyzed by
          Pearson  correlation  analysis  and  binary  Logistic  regression  analysis,  and  the  nonparametric  test  and  chi-square  test  were  used  to
          rank  and  analyze  the  consistency  of  the  factors  affecting  patients’  preference  decision.  RESULTS  A  total  of  140  questionnaires
          were collected, and the effective recovery rate was 77.35%. The average preference score of 140 patients to receive MPA TDM was
                                                             (4.01±0.65),  and  the  overall  preference  value  was  high.
              Δ 基金项目 国家自然科学基金项目(No.72074005)                  There  were  116 (82.86%)  patients  agreed  or  strongly  agreed
             *第一作者 药师,硕士。研究方向:循证药学、治疗药物监测。                    with  MPA  TDM.  Significant  differences  were  observed  in
          E-mail:liushuang@bjmu.edu.cn
                                                              preference  scores  between  patients  who  had  previously
              # 通信作者 主任医师,博士生导师,博士。研究方向:同种异
          体或亲属肾脏、胰肾联合、血管等移植及常见泌尿系疾病。E-mail:                   undergone  MPA  TDM  and  those  who  had  never  undergone  it
          houxf12@163.com                                     [ (4.30±0.53)  scores  vs.  (3.80±0.65)  scores,  P<0.001].


          · 90 ·    China Pharmacy  2024 Vol. 35  No. 1                                中国药房  2024年第35卷第1期
   95   96   97   98   99   100   101   102   103   104   105